Potomac, MD, United States of America

Ira H Pastan

USPTO Granted Patents = 126 

 

 

Average Co-Inventor Count = 3.2

ph-index = 29

Forward Citations = 2,265(Granted Patents)


Inventors with similar research interests:


Location History:

  • Potamac, MD (US) (2008)
  • Bethesda, MD (US) (2014)
  • Potomac, MD (US) (1983 - 2021)
  • Chevy Chase, MD (US) (2022 - 2023)

Company Filing History:

goldMedal73 out of 3,435 
 
National Institutes of Health, a Component of the US Dept. of Health & Human Services
 patents
silverMedal32 out of 1,215 
 
The United States of America As Represented by the Department of Health
 patents
bronzeMedal10 out of 2,202 
 
The United States of America As Represented by the Secretary of
 patents
410 out of 2,007 
 
Duke University
 patents
53 out of 254 
 
The United States of America
 patents
62 out of 43 
 
National Institutes of Health
 patents
71 out of 29 
 
Protein Design Labs, Inc.
 patents
81 out of 2,340 
 
University of Illinois
 patents
91 out of 212 
 
Cetus Corporation
 patents
101 out of 4,942 
 
Hoffmann-la Roche Inc.
 patents
111 out of 2 
 
Sanford Research
 patents
121 out of 1 
 
Secretary, Dhhs
 patent
131 out of 8,684 
 
US Government As Represented by the Secretary of the Army
 patents
141 out of 1 
 
University of Delhi Department of Biochemistry
 patent
151 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1983-2025

Loading Chart...
Loading Chart...
Loading Chart...
126 patents (USPTO):

Title: Innovations in Cancer Treatment: The Patented Work of Ira H. Pastan

Introduction

Ira H. Pastan is a prominent figure in the field of molecular biology and cancer research, based in Potomac, MD. With a prolific portfolio comprising 88 patents, Pastan has made significant contributions to the development of innovative therapies aimed at treating various cancers. His work highlights the intersection of science and technology, pushing the boundaries of how we understand and combat disease.

Latest Patents

Among his most recent patents is the development of immunotoxins with an albumin binding domain. This innovative molecule comprises multiple domains: a targeting moiety, an albumin binding domain, a furin cleavage sequence, and an optionally substituted Domain III from exotoxin A. This patent not only includes the molecule itself but also related nucleic acids, expression vectors, host cells, and pharmaceutical compositions that detail methods for treating cancer in mammals and inhibiting the growth of target cells.

Another significant patent involves cross-species single domain antibodies that target mesothelin, a protein commonly associated with solid tumors. This research highlights camel single-domain monoclonal antibodies specifically designed to bind human and mouse mesothelin. The innovative aspects of this patent include chimeric antigen receptor (CAR) T cells and antibody conjugates utilizing these mesothelin-specific antibodies, providing promising avenues for diagnosing and treating mesothelin-positive cancers.

Career Highlights

Ira H. Pastan has enjoyed a distinguished career, marked by an unwavering commitment to harnessing the potential of immunotherapy in oncology. He has had tenures at esteemed organizations such as the United States Department of Health and Human Services, where he contributed his expertise in developing therapies that aim to improve cancer treatment outcomes. His innovative approach has earned him recognition and respect within the scientific community.

Collaborations

Throughout his career, Pastan has collaborated with several esteemed colleagues, including Masanori Onda and Byungkook Lee. These collaborations have fostered advancements in cancer therapeutics, combining diverse expertise to push the frontiers of medical science and enhance treatment precision.

Conclusion

Ira H. Pastan's contributions to science through his patents underscore the critical role of innovation in combating diseases, especially cancer. His work on immunotoxins and antibody-based therapies has not only advanced our understanding of targeted treatment but also paved the way for future research aimed at eradicating cancer. As he continues to push the boundaries of what is possible in the realm of molecular biology, Pastan serves as an inspiration to current and future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…